ACHV
Achieve Life Sciences Inc.
$3.96
+$0.08(+2.06%)
47
Overall
40
Value
54
Tech
--
Quality
Market Cap
$256.06M
Volume
434.24K
52W Range
$1.84 - $5.78
Target Price
$16.33
Company Overview
| Mkt Cap | $256.06M | Price | $3.96 |
| Volume | 434.24K | Change | +2.06% |
| P/E Ratio | -6.4 | Open | $3.91 |
| Revenue | -- | Prev Close | $3.88 |
| Net Income | $-39.8M | 52W Range | $1.84 - $5.78 |
| Div Yield | N/A | Target | $16.33 |
| Overall | 47 | Value | 40 |
| Quality | -- | Technical | 54 |
No chart data available
About Achieve Life Sciences Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc., which is headquartered in Vancouver, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest News
Achieve Life Sciences Reports Q3 2025 Results
TipRanks Auto-Generated Newsdesk•17 days ago
Achieve Life Sciences: Key Insights from Earnings Call
TipRanks Auto-Generated Newsdesk•17 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACHV | $3.96 | +2.1% | 434.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Achieve Life Sciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW